| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,791 |
2,656 |
$230K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,131 |
2,949 |
$218K |
| S9083 |
Global fee urgent care centers |
1,681 |
1,558 |
$122K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,160 |
1,125 |
$84K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,333 |
1,232 |
$50K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
268 |
251 |
$18K |
| 87428 |
|
179 |
169 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
553 |
540 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
46 |
44 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
32 |
32 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
214 |
105 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$713.02 |
| 99050 |
|
52 |
51 |
$695.31 |
| S8301 |
Infection control supplies, not otherwise specified |
423 |
404 |
$554.72 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
12 |
$65.08 |
| 81003 |
|
51 |
46 |
$48.59 |
| 99000 |
|
33 |
31 |
$30.78 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
17 |
$0.00 |